Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells

Molecular and Cellular Biology
Shala DezfouliPeter J Hurlin

Abstract

Mnt is a Max-interacting protein that can antagonize the activities of Myc oncoproteins in cultured cells. Mnt null mice die soon after birth, but conditional deletion of Mnt in breast epithelium leads to tumor formation. These and related data suggest that Mnt functions as a tumor suppressor. Here we show that conditional deletion of Mnt in T cells leads to tumor formation but also causes inflammatory disease. Deletion of Mnt caused increased apoptosis of thymic T cells and interfered with T-cell development yet led to spleen, liver, and lymph node enlargement. The proportion of T cells in the spleen and lymph nodes was reduced, and the numbers of cells in non-T-cell immune cell populations were elevated. The disruption of immune homeostasis is linked to a strong skewing toward production of T-helper 1 (Th1) cytokines and enhanced proliferation of activated Mnt-deficient CD4+ T cells. Consistent with Th1 polarization in vivo, extensive intestinal inflammation and liver necrosis developed. Finally, most mice lacking Mnt in T cells ultimately succumbed to T-cell lymphoma. These results strengthen the argument that Mnt functions as a tumor suppressor and reveal a critical and surprising role for Mnt in the regulation of T-cell de...Continue Reading

References

Jan 1, 1991·Annual Review of Immunology·W van Ewijk
May 2, 1994·Journal of Immunological Methods·A B Lyons, C R Parish
Apr 1, 1993·International Journal of Cancer. Journal International Du Cancer·M StewartJ C Neil
Jan 1, 1996·British Journal of Cancer·E R CameronD E Onions
Apr 1, 1997·Current Opinion in Immunology·H J Fehling, H von Boehmer
Sep 17, 1999·Molecular Cell·D W Felsher, J M Bishop
Mar 14, 2000·Cell Death and Differentiation·E R CameronK Blyth
Nov 30, 2000·Arthritis Research·C Dong, R A Flavell
Mar 29, 2001·Nature Immunology·N C DouglasA C Hayday
Oct 31, 2001·Trends in Cell Biology·Z Q Zhou, P J Hurlin
Mar 22, 2002·Nature Reviews. Immunology·John J O'SheaPeter Lipsky
May 30, 2002·Nature Reviews. Immunology·Ronald N Germain
Jun 4, 2002·Nature Medicine·Markus F NeurathLaurie H Glimcher
Jul 9, 2002·Nature Immunology·Li ZhangKodi S Ravichandran
Oct 3, 2002·Nature Reviews. Cancer·Stella PelengarisGerard Evan
Apr 16, 2003·Genes & Development·Amir OrianRobert N Eisenman
Sep 13, 2003·The EMBO Journal·Peter J HurlinAnthony Wynshaw-Boris
Oct 1, 2003·Molecular and Cellular Biology·Kirsteen H MacleanJohn L Cleveland
Nov 25, 2003·Current Opinion in Immunology·Pamela S Ohashi
Dec 10, 2003·Oncogene·Jonas A Nilsson, John L Cleveland
Jan 30, 2004·Molecular and Cellular Biology·Jonas A NilssonJohn L Cleveland
Jul 30, 2004·The EMBO Journal·Gretchen PoortingaRoss D Hannan
Mar 2, 2005·Nature Cell Biology·Thordur Oskarsson, Andreas Trumpp
Apr 19, 2005·Arthritis Research & Therapy·Alla SkapenkoHendrik Schulze-Koops
May 4, 2005·The Journal of Cell Biology·William WalkerPeter J Hurlin

❮ Previous
Next ❯

Citations

Nov 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jason M LinkPeter J Hurlin
Mar 31, 2011·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Benjamin KopeckyBernd Fritzsch
Aug 16, 2006·Seminars in Cancer Biology·Peter J Hurlin, Jie Huang
Apr 16, 2014·Biochimica Et Biophysica Acta·Jason M Link, Peter J Hurlin
May 27, 2014·Biochimica Et Biophysica Acta·Daniel DiolaitiRobert N Eisenman
Jan 18, 2013·Cell Cycle·Jason M Link, Peter J Hurlin
Feb 24, 2017·Genes·Guang Yang, Peter J Hurlin
Mar 9, 2018·Medical Sciences : Open Access Journal·Rebecca S HesterbergPearlie K Epling-Burnette
Aug 12, 2017·Cell Death and Differentiation·Kirsteen J CampbellSuzanne Cory
Jul 29, 2018·Frontiers of Medicine·Patrick A CarrollRobert N Eisenman
Jun 19, 2012·Cancer Research·Alberto Cascón, Mercedes Robledo
Jan 10, 2021·Oncogenesis·Judit Liaño-PonsJavier León

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis